Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-05-09
1989-06-06
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 530331, A61K 3743, C07K 508
Patent
active
048372048
ABSTRACT:
The invention relates to renin inhibiting compounds of the formula ##STR1## wherein A is hydrogen; loweralkyl; aryalkyl; OR.sub.8 or SR.sub.8 wherein R.sub.8 is hydrogen, loweralkyl or aminoalkyl; NR.sub.9 R.sub.10 wherein R.sub.9 and R.sub.10 are independently selected from hydrogen, loweralkyl, aminoalkyl, cyanoalkyl and hydroxyalkyl; ##STR2## wherein B is NH, alkylamino, S, O, CH.sub.2 or CHOH and R.sub.11 is loweralkyl, cycloalkyl, aryl, arylalkyl, alkoxy, alkenyloxy, hydroxyalkoxy, dihydroxyalkoxy, arylalkoxy, arylalkoxyalkyl, amino, alkylamino, dialkylamino, (hydroxyalkyl)(alkyl)amino, (dihydroxyalkyl)(alkyl)amino, carboxylic acid-substituted alkyl, alkoxycarbonylalkyl, aminoalkyl, N-protected aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, (N-protected)-(alkyl)aminoalkyl, (heterocyclic)alkyl or a substituted or unsubstituted heterocyclic; R.sub.1 is loweralkyl, cycloalkylmethyl, benzyl, .alpha.-methylbenzyl, .alpha.,.alpha.-dimethylbenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)-methyl, (2-naphthyl)methyl, (4-imidazolyl)methyl, phenethyl, phenoxy, thiophenoxy or anilino; provided if R.sub.1 is henoxy, thiophenoxy or anilino, B is CH.sub.2 or CHOH or A is hydrogen; R.sub.3 is loweralkyl, benzyl or heterocyclic ring-substituted methyl; R.sub.4 is loweralkyl, cycloalkyl- methyl or benzyl; R.sub.2, R.sub.5 and R.sub.6 are independently hydrogen or loweralkyl; X is O, NH or S; R.sub.7 is hydrogen, loweralkyl, alkanoyl, alkylsulfonyl ##STR3## wherein R.sub.12 and R.sub.13 are independently hydrogen or loweralkyl, n is 0-2 and R.sub.14 is substituted or unsubstituted phenyl or heterocyclic; or XR.sub.7 together are loweralkylsulfonyl, N.sub.3 or Cl, and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4645759 (1987-02-01), Luly et al.
patent: 4652551 (1987-03-01), Luly et al.
patent: 4657931 (1987-04-01), Baran et al.
T. Kokubu et al., Hypertension, Supp. I, I-8, I-11 (1985), "Highly Potent and Specific Inhibitors of Human Renin".
R. Matsueda et al., Chemistry Letters 1041-1044 (1985), "Short Chain Peptide Inhibitors of Human Renin".
G. Hanson et al., Biochem. Biophys. Res. Commun. 132 155-161 (1985), "Dipeptide Glycols: A New Class of Renin Inhibitors".
Luly Jay R.
Plattner Jacob J.
Rosenberg Saul H.
Abbott Laboratories
Crowley Steven R.
Katz Martin L.
Phillips Delbert R.
Roth Michael J.
LandOfFree
Functionalized peptidyl aminodiols and -triols does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functionalized peptidyl aminodiols and -triols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functionalized peptidyl aminodiols and -triols will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-40642